These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 33506903)

  • 1. Upregulation of serum exosomal SUMO1P3 predicts unfavorable prognosis in triple negative breast cancer.
    Na-Er A; Xu YY; Liu YH; Gan YJ
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):154-160. PubMed ID: 33506903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum lncRNA TINCR Serve as a Novel Biomarker for Predicting the Prognosis in Triple-Negative Breast Cancer.
    Wang X; Li S; Xiao H; Deng X
    Technol Cancer Res Treat; 2020; 19():1533033820965574. PubMed ID: 33084530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serum exosomal long non-coding RNA SNHG15 expression predicts poor prognosis in non-small cell lung cancer.
    Han P; Zhao J; Gao L
    J Clin Lab Anal; 2021 Nov; 35(11):e23979. PubMed ID: 34551140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA T376626 is a promising serum biomarker and promotes proliferation, migration, and invasion via binding to LAMC2 in triple-negative breast cancer.
    He Y; Xiao B; Lei T; Xuan J; Zhu Y; Kuang Z; Liu J; He J; Li L; Sun Z
    Gene; 2023 Apr; 860():147227. PubMed ID: 36709879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High serum exosomal long non-coding RNA DANCR expression confers poor prognosis in patients with breast cancer.
    Shi W; Jin X; Wang Y; Zhang Q; Yang L
    J Clin Lab Anal; 2022 Mar; 36(3):e24186. PubMed ID: 35150011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of SUMO1 pseudogene 3 (SUMO1P3) in gastric cancer and its clinical association.
    Mei D; Song H; Wang K; Lou Y; Sun W; Liu Z; Ding X; Guo J
    Med Oncol; 2013 Dec; 30(4):709. PubMed ID: 23996296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SUMO1P3 is associated clinical progression and facilitates cell migration and invasion through regulating miR-136 in non-small cell lung cancer.
    Zhang Y; Li Y; Han L; Zhang P; Sun S
    Biomed Pharmacother; 2019 May; 113():108686. PubMed ID: 30851548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer.
    Liu T; Zhang X; Gao S; Jing F; Yang Y; Du L; Zheng G; Li P; Li C; Wang C
    Oncotarget; 2016 Dec; 7(51):85551-85563. PubMed ID: 27888803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of serum exosomal lncRNA MIAT as a novel diagnostic and prognostic biomarker for gastric cancer.
    Xu H; Zhou J; Tang J; Min X; Yi T; Zhao J; Ren Y
    J Clin Lab Anal; 2020 Aug; 34(8):e23323. PubMed ID: 32274858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long Noncoding RNA Highly Up-regulated in Liver Cancer Predicts Unfavorable Outcome and Regulates Metastasis by MMPs in Triple-negative Breast Cancer.
    Shi F; Xiao F; Ding P; Qin H; Huang R
    Arch Med Res; 2016 Aug; 47(6):446-453. PubMed ID: 27986124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of novel three-long noncoding RNA signatures as a diagnostic and prognostic biomarkers of human triple-negative breast cancer.
    Fan CN; Ma L; Liu N
    J Cell Biochem; 2019 Mar; 120(3):3185-3196. PubMed ID: 30203490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum exosomal lncRNA XIST is a potential non-invasive biomarker to diagnose recurrence of triple-negative breast cancer.
    Lan F; Zhang X; Li H; Yue X; Sun Q
    J Cell Mol Med; 2021 Aug; 25(16):7602-7607. PubMed ID: 33949761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA HAND2-AS1 suppressed the growth of triple negative breast cancer via reducing secretion of MSCs derived exosomal miR-106a-5p.
    Xing L; Tang X; Wu K; Huang X; Yi Y; Huan J
    Aging (Albany NY); 2020 Dec; 13(1):424-436. PubMed ID: 33290256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of SUMO1P3 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer.
    Zhan Y; Liu Y; Wang C; Lin J; Chen M; Chen X; Zhuang C; Liu L; Xu W; Zhou Q; Sun X; Zhang Q; Zhao G; Huang W
    Oncotarget; 2016 Mar; 7(13):16038-48. PubMed ID: 26799188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploration of Serum Exosomal LncRNA TBILA and AGAP2-AS1 as Promising Biomarkers for Diagnosis of Non-Small Cell Lung Cancer.
    Tao Y; Tang Y; Yang Z; Wu F; Wang L; Yang L; Lei L; Jing Y; Jiang X; Jin H; Bai Y; Zhang L
    Int J Biol Sci; 2020; 16(3):471-482. PubMed ID: 32015683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revealing the role of serum exosomal novel long non-coding RNA NAMPT-AS as a promising diagnostic/prognostic biomarker in colorectal cancer patients.
    Rizk NI; Kassem DH; Abulsoud AI; AbdelHalim S; Yasser MB; Kamal MM; Hamdy NM
    Life Sci; 2024 Sep; 352():122850. PubMed ID: 38901687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of serum exosomal miR-148a as a novel prognostic biomarker for breast cancer.
    Li D; Wang J; Ma LJ; Yang HB; Jing JF; Jia MM; Zhang XJ; Guo F; Gao JN
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7303-7309. PubMed ID: 32706068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.
    Rodríguez Bautista R; Ortega Gómez A; Hidalgo Miranda A; Zentella Dehesa A; Villarreal-Garza C; Ávila-Moreno F; Arrieta O
    Clin Epigenetics; 2018; 10():88. PubMed ID: 29983835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A three-long noncoding RNA signature as a diagnostic biomarker for differentiating between triple-negative and non-triple-negative breast cancers.
    Liu M; Xing LQ; Liu YJ
    Medicine (Baltimore); 2017 Mar; 96(9):e6222. PubMed ID: 28248879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA HUMT hypomethylation promotes lymphangiogenesis and metastasis via activating FOXK1 transcription in triple-negative breast cancer.
    Zheng S; Yang L; Zou Y; Liang JY; Liu P; Gao G; Yang A; Tang H; Xie X
    J Hematol Oncol; 2020 Mar; 13(1):17. PubMed ID: 32138762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.